
Bylenta Trio 40mg/10mg/12.5mg Tablet
Marketer
Lloyd Healthcare Pvt Ltd
Salt Composition
Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg)
Overview Bylenta Trio 40mg/10mg/12.5mg Tablet
Tricordil HP 40mg/10mg/12.5mg tablets combine three medications to effectively manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, thereby mitigating the risk of future strokes and heart attacks. Administer Tricordil HP 40mg/10mg/12.5mg tablets with food, following your physician's prescribed dosage based on your individual needs and response. Maintain consistent daily timing. Continue treatment as directed by your doctor; discontinuation may elevate stroke or heart attack risk. The diuretic component increases urination; avoid dosing within four hours of bedtime. Consistent use is crucial for optimal results, even during symptom-free periods, as hypertension often presents asymptomatically. Common side effects include fatigue, altered taste perception, dizziness, headaches, and ankle edema. Report any persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to counter potential side effects such as thirst, dry mouth, or muscle weakness. Prior to initiating treatment, disclose any pre-existing liver or kidney conditions, pregnancy, or breastfeeding. Inform your doctor of all concurrent medications, particularly those for cardiovascular issues or hypertension. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is necessary to ensure therapeutic efficacy.
Uses of Bylenta Trio 40mg/10mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Bylenta Trio 40mg/10mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Bylenta Trio 40mg/10mg/12.5mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Bylenta Trio 40mg/10mg/12.5mg Tablet:
- Ankle swelling
- Headache
- Dizziness
- Tiredness
- Palpitations
- Sleepiness
- Increased blood uric acid
- Glucose intolerance
- Taste change
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Upset stomach
- Altered blood lipid level
How to use Bylenta Trio 40mg/10mg/12.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Bylenta Trio 40mg/10mg/12.5mg Tablet should be administered with a meal.
How Bylenta Trio 40mg/10mg/12.5mg Tablet works:
Bylenta Trio tablets (40mg/10mg/12.5mg) combine telmisartan, cilnidipine, and chlorthalidone to manage hypertension. Telmisartan, an ARB, and cilnidipine, a CCB, act synergistically to dilate blood vessels, reducing blood pressure. Chlorthalidone, a diuretic, enhances this effect by promoting fluid excretion and further vasodilation, improving circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Combining Bylenta Trio 40mg/10mg/12.5mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Bylenta Trio 40mg/10mg/12.5mg tablets is contraindicated during pregnancy due to confirmed risk to the fetus. Exceptions may be made by a physician in life-threatening circumstances where potential benefits outweigh known hazards. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Bylenta Trio 40mg/10mg/12.5mg tablets with breastfeeding are lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking a Bylenta Trio 40mg/10mg/12.5mg tablet may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Bylenta Trio 40mg/10mg/12.5mg tablets, potentially requiring dosage modification. Physician consultation is advised; this medication is generally not recommended for such individuals.
LiverCAUTION
Patients with hepatic impairment should use Bylenta Trio 40mg/10mg/12.5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. The use of Bylenta Trio 40mg/10mg/12.5mg tablets is contraindicated in individuals with severe liver disease.
What if you forget to take Bylenta Trio 40mg/10mg/12.5mg Tablet :
Should you forget a Bylenta Trio 40mg/10mg/12.5mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bylenta Trio 40mg/10mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
